Embecta Corp.

AI Score

0

Unlock

18.75
0.12 (0.64%)
At close: Jan 22, 2025, 3:59 PM
18.74
-0.05%
After-hours Jan 22, 2025, 04:00 PM EST

Company Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.

Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.

The company primarily sells its products to wholesalers and distributors in the United States and internationally.

Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.

Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

Embecta Corp.
Embecta Corp. logo
Country United States
IPO Date Mar 22, 2022
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,200
CEO Devdatt Kurdikar

Contact Details

Address:
300 Kimball Drive
Parsippany, New Jersey
United States
Website https://www.embecta.com

Stock Details

Ticker Symbol EMBC
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001872789
CUSIP Number 29082K105
ISIN Number US29082K1051
Employer ID 87-1583942
SIC Code 3841

Key Executives

Name Position
Devdatt Kurdikar President, Chief Executive Officer & Director
Colleen Riley Senior Vice President & Chief Technology Officer
Jacob P. Elguicze Senior Vice President & Chief Financial Officer
Ginny Blocki Senior Vice President of Global Marketing & Product Management
Jean M. Casner Senior Vice President & Chief Human Resources Officer
Jeffrey Z. Mann Senior Vice President, General Counsel, Head of Business Development & Corporate Secretary
Pravesh Khandelwal Vice President & Head of Investor Relations
Shaun Curtis Senior Vice President of Global Manufacturing & Supply Chain
Slobodan Radumilo Senior Vice President & President of International
Tom Blount Senior Vice President & President of North America

Latest SEC Filings

Date Type Title
Dec 19, 2024 ARS Filing
Dec 19, 2024 DEFA14A Filing
Dec 19, 2024 DEF 14A Filing
Dec 11, 2024 10-K Annual Report
Dec 04, 2024 4 Filing
Dec 04, 2024 3 Filing
Dec 02, 2024 8-K Current Report
Nov 29, 2024 NT 10-K Filing
Nov 29, 2024 4 Filing
Nov 29, 2024 4 Filing